Logotipo do repositório
 

Publicação:
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

dc.contributor.authorRider, Lisa G.
dc.contributor.authorAggarwal, Rohit
dc.contributor.authorPistorio, Angela
dc.contributor.authorBayat, Nastaran
dc.contributor.authorErman, Brian
dc.contributor.authorFeldman, Brian M.
dc.contributor.authorHuber, Adam M.
dc.contributor.authorCimaz, Rolando
dc.contributor.authorCuttica, Ruben J.
dc.contributor.authorOliveira, Sheila Knupp de
dc.contributor.authorLindsley, Carol B.
dc.contributor.authorPilkington, Clarissa A.
dc.contributor.authorPunaro, Marilynn
dc.contributor.authorRavelli, Angelo
dc.contributor.authorReed, Ann M.
dc.contributor.authorRouster-Stevens, Kelly
dc.contributor.authorvan Royen-Kerkhof, Annet
dc.contributor.authorDressler, Frank
dc.contributor.authorMagalhaes, Claudia Saad [UNESP]
dc.contributor.authorConstantin, Tamas
dc.contributor.authorDavidson, Joyce E.
dc.contributor.authorMagnusson, Bo
dc.contributor.authorRusso, Ricardo
dc.contributor.authorVilla, Luca
dc.contributor.authorRinaldi, Mariangela
dc.contributor.authorRockette, Howard
dc.contributor.authorLachenbruch, Peter A.
dc.contributor.authorMiller, Frederick W.
dc.contributor.authorVencovsky, Jiri
dc.contributor.authorRuperto, Nicolino
dc.contributor.authorInt Myositis Assessment Clinical
dc.contributor.authorPaediat Rheumatology Int Trials
dc.contributor.institutionNIEHS
dc.contributor.institutionUniv Pittsburgh
dc.contributor.institutionIst Giannina Gaslini
dc.contributor.institutionSocial & Sci Syst Inc
dc.contributor.institutionHosp Sick Children
dc.contributor.institutionIWK Hlth Ctr
dc.contributor.institutionUniv Florence
dc.contributor.institutionUniv Buenos Aires
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionUniv Kansas City
dc.contributor.institutionGreat Ormond St Hosp Sick Children
dc.contributor.institutionUniv Texas Southwestern Med Ctr Dallas
dc.contributor.institutionUniv Genoa
dc.contributor.institutionDuke Univ
dc.contributor.institutionEmory Univ
dc.contributor.institutionUniv Med Ctr Utrecht
dc.contributor.institutionHannover Med Sch
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionSemmelweis Univ
dc.contributor.institutionRoyal Hosp Sick Children
dc.contributor.institutionKarolinska Univ Hosp
dc.contributor.institutionHosp Pediat Garrahan
dc.contributor.institutionPRINTO
dc.contributor.institutionCharles Univ Prague
dc.date.accessioned2018-11-28T10:07:48Z
dc.date.available2018-11-28T10:07:48Z
dc.date.issued2017-05-01
dc.description.abstractObjective. To develop response criteria for juvenile dermatomyositis (DM). Methods. We analyzed the performance of 312 definitions that used core set measures from either the International Myositis Assessment and Clinical Studies Group (IMACS) or the Paediatric Rheumatology International Trials Organisation (PRINTO) and were derived from natural history data and a conjoint analysis survey. They were further validated using data from the PRINTO trial of prednisone alone compared to prednisone with methotrexate or cyclosporine and the Rituximab in Myositis (RIM) trial. At a consensus conference, experts considered 14 top candidate criteria based on their performance characteristics and clinical face validity, using nominal group technique. Results. Consensus was reached for a conjoint analysis-based continuous model with a total improvement score of 0-100, using absolute percent change in core set measures of minimal (>= 30), moderate (>= 45), and major (>= 70) improvement. The same criteria were chosen for adult DM/polymyositis, with differing thresholds for improvement. The sensitivity and specificity were 89% and 91-98% for minimal improvement, 92-94% and 94-99% for moderate improvement, and 91-98% and 85-86% for major improvement, respectively, in juvenile DM patient cohorts using the IMACS and PRINTO core set measures. These criteria were validated in the PRINTO trial for differentiating between treatment arms for minimal and moderate improvement (P=0.009-0.057) and in the RIM trial for significantly differentiating the physician's rating for improvement (P<0.006). Conclusion. The response criteria for juvenile DM consisted of a conjoint analysis-based model using a continuous improvement score based on absolute percent change in core set measures, with thresholds for minimal, moderate, and major improvement.en
dc.description.affiliationNIEHS, NIH, Bethesda, MD USA
dc.description.affiliationUniv Pittsburgh, Pittsburgh, PA USA
dc.description.affiliationIst Giannina Gaslini, Serv Epidemiol & Biostat, Genoa, Italy
dc.description.affiliationSocial & Sci Syst Inc, Durham, NC USA
dc.description.affiliationHosp Sick Children, Toronto, ON, Canada
dc.description.affiliationIWK Hlth Ctr, Halifax, NS, Canada
dc.description.affiliationUniv Florence, Florence, Italy
dc.description.affiliationUniv Buenos Aires, Hosp Ninos Pedro de Elizalde, Buenos Aires, DF, Argentina
dc.description.affiliationUniv Fed Rio de Janeiro, Rio De Janeiro, Brazil
dc.description.affiliationUniv Kansas City, Med Ctr, Kansas City, KS USA
dc.description.affiliationGreat Ormond St Hosp Sick Children, London, England
dc.description.affiliationUniv Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
dc.description.affiliationUniv Genoa, Pediat Reumatol 2, Ist Giannina Gaslini, Genoa, Italy
dc.description.affiliationDuke Univ, Durham, NC USA
dc.description.affiliationEmory Univ, Sch Med, Atlanta, GA USA
dc.description.affiliationUniv Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands
dc.description.affiliationHannover Med Sch, Hannover, Germany
dc.description.affiliationUniv Estadual Paulista, Botucatu, SP, Brazil
dc.description.affiliationSemmelweis Univ, Budapest, Hungary
dc.description.affiliationRoyal Hosp Sick Children, Glasgow, Lanark, Scotland
dc.description.affiliationRoyal Hosp Sick Children, Edinburgh, Midlothian, Scotland
dc.description.affiliationKarolinska Univ Hosp, Stockholm, Sweden
dc.description.affiliationHosp Pediat Garrahan, Buenos Aires, DF, Argentina
dc.description.affiliationPRINTO, Ist Giannina Gaslini, Pediat Reumatol 2, Genoa, Italy
dc.description.affiliationCharles Univ Prague, Prague, Czech Republic
dc.description.affiliationUnespUniv Estadual Paulista, Botucatu, SP, Brazil
dc.description.sponsorshipAmerican College of Rheumatology
dc.description.sponsorshipEuropean League Against Rheumatism
dc.description.sponsorshipNIH (National Institute of Environmental Health Sciences [NIEHS])
dc.description.sponsorshipNIH (National Center for Advancing Translational Sciences)
dc.description.sponsorshipNIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases)
dc.description.sponsorshipIstituto G. Gaslini
dc.description.sponsorshipPaediatric Rheumatology International Trials Organisation (PRINTO)
dc.description.sponsorshipCure JM Foundation
dc.description.sponsorshipMyositis UK
dc.description.sponsorshipMyositis Association
dc.description.sponsorshipMinistry of Health, Czech Republic (Institute of Rheumatology project for conceptual development of a research organization)
dc.description.sponsorshipIdMinistry of Health, Czech Republic (Institute of Rheumatology project for conceptual development of a research organization): 00023728
dc.format.extent911-923
dc.identifierhttp://dx.doi.org/10.1002/art.40060
dc.identifier.citationArthritis & Rheumatology. Hoboken: Wiley, v. 69, n. 5, p. 911-923, 2017.
dc.identifier.doi10.1002/art.40060
dc.identifier.issn2326-5191
dc.identifier.lattes7098310008371632
dc.identifier.orcid0000-0002-7631-7093
dc.identifier.urihttp://hdl.handle.net/11449/165585
dc.identifier.wosWOS:000400068300005
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofArthritis & Rheumatology
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.title2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiativeen
dc.typeArtigo
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-Blackwell
dspace.entity.typePublication
unesp.author.lattes7098310008371632[19]
unesp.author.orcid0000-0002-6895-8720[3]
unesp.author.orcid0000-0002-1256-8483[23]
unesp.author.orcid0000-0002-7631-7093[19]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentPediatria - FMBpt

Arquivos